AzTrials
AzTrials

Pain IntensityTVNS_TSP_LBPNCT04503889

The Effect of Transauricular Electrical Vagal Nerve Stimulation on Temporal Summation of Pain in Patients With Back Pain

A study testing Transauricular electrical vagal nerve stimulation in people with Pain Intensity, run by University Medicine Greifswald at 1 site in Germany.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The effect of transauricular electrical vagal nerve stimulation (taVNS) will be studied on temporal summation of heat pain (TSP) in 30 patients with chronic low-back pain and in 30 heathy volunteers. Read more about this study

Who is it for?
Ages 30 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Pain Intensity
What is being tested?
Transauricular electrical vagal nerve stimulation
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
60 participants
Where
1 siteGermany
Study dates
23 Jan 2019to Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Patients with chronic low-back pain
  • age 30-60 yrs old
  • without heart disease
  • low-back pain intensity at least 4 out of 10 points measured using NRS-10
  • without cognitive deficits (Mini Mental State Shake < 23)

Who cannot join

  • opioid medication
  • more than 1 low-back surgery
  • sensory of motor neurological deficits at the level of back pain
  • spinal stenosis
  • diabetic polyneuropathy
  • skin pathology at the site (cymba conchae) of stimulation

Trial locations and contacts

1 site in 1 country.

Taras Usichenko, MD. PhD contact

+49 383486 ext. 5893

taras@uni-greifswald.de

David Naegele contact

david.naegele@uni-greifswald.de

Germany1 site, 1 recruiting
  • University Medicine of Greifswald

    Greifswald, 17475

    Taras Usichenko, MD, hD, +49383486 ext. 5893, taras@uni-greifswald.de

    David Naegele, david.naegele@uni-greifswald.de

    Recruiting

Other trials in Germany

About this study

Official title: The Effect of Transauricular Electrical Vagal Nerve Stimulation on Temporal Summation of Heat Pain in Patients With Chronic Low-back Pain

The effect of transauricular electrical vagal nerve stimulation (taVNS) will be studied on temporal summation of heat pain (TSP) in 30 patients with chronic low-back pain and in 30 heathy volunteers. Participants will receive either taVNS or sham stimulation before and during TSP induction in a randomized crossover manner. The participants will be unaware regarding the type of intervention.

Conditions
Pain Intensity
Being tested
Transauricular electrical vagal nerve stimulation, taVNS sham
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transauricular electrical vagal nerve stimulationDevice

    transauricular electrical vagal nerve stimulation will be applied to the cymba conchae of both ears using ECO2 TENS device (manufactured by Schwa-Medico GmbH/Germany) with currency intensity of max 10 mA and current frequency 2/100 Hz.

  • taVNS shamDevice

    ECO2 TENS device (manufactured by Schwa-Medico GmbH/Germany)

Study groups in NCT04503889
Study groupRoleWhat they receive
Real taVNS interventionExperimentaltaVNS will be administered to cymba conchae of both ears using ECO2-TENS device
Receives: Device: Transauricular electrical vagal nerve stimulation; Device: taVNS sham
ShamSham comparatoraVNS will be administered to lobes of both ears using ECO2-TENS device
Receives: Device: Transauricular electrical vagal nerve stimulation; Device: taVNS sham

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Unpleasantness of pain

    Perceived unpleasantness of pain, which participants will rate continuously during the repetitive heat stimulation using a computerized visual analogue scale (CoVAS, Medoc Advanced Medical Systems, Ramat Yishai, Israel) ranging from 0 (= not unpleasant at all) to 100 (= intolerable pain)

    Measured: Continuously 5 minutes during the experimental heat pain stimulation

Secondary outcomes (2)
  1. Heart rate

    Heart rate (bpm)

    Measured: 10 minutes (before, during and after stimulation of heat pain)

  2. blood pressure

    non-invasive measurement of systolic and diastolic blood pressure

    Measured: 10 minutes (before, during and after stimulation of heat pain)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Aug 2020
  2. Study start23 Jan 2019
  3. Primary completionDec 2021 (estimated)
  4. Study completionDec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04503889
Sponsor's protocol ID
BB 095/16
Acronym
TVNS_TSP_LBP
Status last verified
Jul 2020
First submitted
31 Jul 2020
Last updated
7 Aug 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Transauricular electrical vagal nerve stimulation in people with Pain Intensity, run by University Medicine Greifswald at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Taras Usichenko, MD. PhD (+49 383486 ext. 5893, taras@uni-greifswald.de), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Unpleasantness of pain (time frame: Continuously 5 minutes during the experimental heat pain stimulation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Aug 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in